Projects funded by the NCN
Involvement of astrocytes in the neuroprotective mechanism evoked by enhancement of noradrenergic transmission in trasngenic mouse model of progressive parkinsonism.
2019/35/N/NZ7/03300
Keywords:
astrocytes neuroprotection neurodegeneration Parkinson's disease transgenic models CRISPR/Cas9
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ3_5: Molecular neurobiology
- NZ5_3: Pathogenesis of human diseases
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 18 - announced on 2019-09-16
Amount awarded: 139 500 PLN
Project start date (Y-m-d): 2020-07-22
Project end date (Y-m-d): 2022-07-21
Project duration:: 24 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.